Cargando…
Waning of SARS-CoV-2 IgG antibodies after vaccination: first results from the CoMoLo follow-up 2021: Cânâ Kußmaul
BACKGROUND: In 2020, the study “Corona-Monitoring Lokal” (CoMoLo) assessed seroprevalences of SARS-CoV-2 IgG antibodies in four study locations that were particularly affected by outbreaks in the early stages of the pandemic in Germany. One of the objectives of the 2021 follow-up was to examine the...
Autores principales: | Kußmaul, C, Schaffrath Rosario, A, Allen, J, Lange, M, Koschollek, C, Haller, S, Schlaud, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593459/ http://dx.doi.org/10.1093/eurpub/ckac129.048 |
Ejemplares similares
-
Socioeconomic differences in contact reduction in the first COVID-19-wave in Germany (CoMoLo-study)
por: Beese, F, et al.
Publicado: (2022) -
SARS-CoV-2 Seroprevalence in Germany: results from the second wave of the RKI-SOEP study: Elisabetta Mercuri
por: Mercuri, E, et al.
Publicado: (2022) -
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
por: Santos-Hövener, Claudia, et al.
Publicado: (2020) -
Non-utilisation of health care services during the COVID-19 pandemic: Results of the CoMoLo study
por: Heidemann, Christin, et al.
Publicado: (2022) -
Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up
por: Heidemann, Christin, et al.
Publicado: (2023)